Zarxio--a filgrastim biosimilar

Med Lett Drugs Ther. 2016 Mar 14;58(1490):34-5.
No abstract available

Publication types

  • Review

MeSH terms

  • Biosimilar Pharmaceuticals*
  • Clinical Trials, Phase I as Topic
  • Drug Approval
  • Female
  • Filgrastim / pharmacology*
  • Filgrastim / therapeutic use*
  • Hematologic Agents / pharmacology*
  • Hematologic Agents / therapeutic use*
  • Humans
  • Randomized Controlled Trials as Topic
  • United States
  • United States Food and Drug Administration

Substances

  • Biosimilar Pharmaceuticals
  • Hematologic Agents
  • Filgrastim